All presenting authors of abstracts have been notified of their acceptance/rejection.
Guidelines will be sent out by mid-September.
Late breaker abstracts are reserved for novel, high-impact research outcomes that were not available by the regular submission deadline. Submissions must present important, time-sensitive findings, such as:
These should have high relevance and impact on HIV care, policy, or research.
Late breaker abstracts must:
Please note: Late breaker abstracts will be rigorously peer reviewed based on the criteria above. The late breaker deadline is not a second deadline for incomplete or delayed submissions.
To participate as a presenter at the EACS Conference, please submit abstracts of your research for inclusion in the conference programme.
We strongly encourage the use of person-first language in all submissions.
All submitted abstracts will be reviewed by a panel of experts. Accepted abstracts will be presented by the authors as either oral presentations or ePosters.
Find the full list of abstract categories HERE.
A maximum of 2 graphics and 2 tables can be uploaded or included in the abstract. These will not add to the word count.
Abstracts presented at the European AIDS Conference must represent original scientific work. Encore submissions, meaning abstracts that have already been presented elsewhere, are not accepted. However, encores that contain substantial new data will be considered.
2. Abstracts accepted at another event
If an abstract has already been accepted for presentation at another scientific event that takes place before the EACS conference, it must be withdrawn from EACS. If the other event takes place after the EACS Conference, the abstract may still be presented at the Conference as original work. In such cases, the subsequent presentation will follow the rules of the other conferences or congresses.
3. Abstracts submitted to journals
– Abstracts that have already led to a full publication before submission for the EACS Conference cannot be presented and must be withdrawn.
– If the corresponding full paper is scheduled for publication only after the Conference, the abstract may still be presented at the Conference, provided this is in line with the journal’s policy. In these situations, authors are strongly encouraged to request an embargo from the journal until the day of their conference presentation.
– For complex or borderline cases (e.g. submission of the paper comes after the submission of the abstract but leads to a full scale publication before the conference), the final decision will be made individually by the EACS President (contact abstracts@eacs-conference.com).
Presenters must be registered for their abstract/clinical case to be included in the conference programme and abstract book. Please note that Exhibition Only registrations are not considered valid for this requirement.
Applications for this programme are closed
To support high-quality abstract submissions, the Programme and Scientific Committees invite EACS members to take advantage of the Abstract Mentorship Programme.
The Governing Board and faculty of the EACS Education and Training Programme have volunteered to offer an online mentoring service for EACS members who are interested in submitting an abstract for the Conference.
This mentorship includes a critical review of the content, style and language of potential abstracts prior to submission.
Please note that participation in the programme does not guarantee abstract acceptance.
For any questions or assistance with your abstract submission, please contact:
EACS Conference Secretariat
c/o K.I.T. Group GmbH
Association & Conference Management
Kurfürstendamm 71
10709 Berlin – Germany
E-mail: abstracts@eacs-conference.com
You need to load content from reCAPTCHA to submit the form. Please note that doing so will share data with third-party providers.
More InformationYou need to load content from Turnstile to submit the form. Please note that doing so will share data with third-party providers.
More InformationYou need to load content from reCAPTCHA to submit the form. Please note that doing so will share data with third-party providers.
More InformationYou are currently viewing a placeholder content from Facebook. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More Information